Autologous Transplantation

Autologous hematopoietic stem cell transplant represents “a useful treatment option” for patients with relapsing MS who experience breakthrough disease activity despite disease-modifying therapy, according to the National MS Society.

Total body irradiation appeared to increase breast cancer risk later in life for women who underwent blood or marrow transplantation for hematologic malignancies — particularly those exposed at age 30 years or younger, study results showed.

Cultivated autologous limbal stem cell transplantation was successfully performed at Massachusetts Eye and Ear in four patients with chemical burns.

An estimated 800 new cases of neuroblastoma are diagnosed in the United States each year.

ORLANDO — Autologous and allogeneic hematopoietic stem cell transplantation both conferred encouraging survival outcomes among patients with Waldenström macroglobulinemia, according to results of a systematic review and meta-analysis presented at TCT | Transplantation & Cellular Therapy Meetings.

Older hematopoietic stem cell transplant survivors appeared 2.6 times more likely to report severe, nonminor or life-threatening pain than cancer-free siblings, according to results of a prospective study published in Cancer.

ORLANDO — In this video, Adam Binder, MD, assistant professor at Thomas Jefferson University, discusses an oral abstract presented at the ASH Annual Meeting and Exposition that revealed melphalan conditioning with autologous hematopoietic stem cell transplantation was safe and effective for patients of all ages with multiple myeloma, particularly those aged 70 years or older.